ISpecimen Net Cash Flow 2020-2025 | ISPC

ISpecimen net cash flow from 2020 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.

ISpecimen Net Cash Flow 2020-2025 | ISPC

ISpecimen net cash flow from 2020 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$147B
CVS Health (CVS)$91.5B
Elevance Health (ELV)$69.9B
Cencora (COR)$56.2B
DiDi Global (DIDIY)$27.4B
Natera (NTRA)$23B
Labcorp Holdings (LH)$22.9B
BioMerieux (BMXMF)$17.4B
EUROFINS SCIENT (ERFSF)$14.6B
ICON (ICLR)$14.1B
Medpace Holdings (MEDP)$13.3B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.6B
Viatris (VTRS)$12.1B
Caris Life Sciences,�Inc (CAI)$10.8B
Revvity (RVTY)$10.4B
Avantor (AVTR)$9B
Charles River Laboratories (CRL)$8B
Sonic Healthcare (SKHHY)$7.8B
HealthEquity (HQY)$7.6B
Bausch + Lomb (BLCO)$5.2B
Sotera Health (SHC)$4.6B
BrightSpring Health Services (BTSG)$4.2B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.7B
Alignment Healthcare (ALHC)$3.2B
Concentras Parent (CON)$3B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.4B
KindlyMD (NAKA)$2.2B